Hexagon Nutrition IPO covers 1.65x on day one as retail piles in at 2.42x
The ₹139-crore issue from the maker of Pentasure and Pediagold drew 2.03x demand from NIIs alongside the retail surge, with anchors already locking in ₹41.66 crore. Grey market premium of ₹6.5 on the ₹42-45 band points to a modest listing pop on June 12.
Hexagon Nutrition's ₹139-crore IPO subscribed 1.65x on day one, led by retail (2.42x) and NII (2.03x). The clinical nutrition company behind Pentasure and Pediagold lists June 12, with GMP at ₹6.5.